Revised Prevalence of Multiple Sclerosis in the Netherlands: New Figures Double Previous Estimates
In a groundbreaking revelation, recent data from Project Y and subsequent analysis by the MS Vereniging Nederland has more than doubled the estimated prevalence of Multiple Sclerosis (MS) in the Netherlands. The new figures suggest that approximately 2.1% of the Dutch population, or 210 people per 100,000 inhabitants, are living with MS. This significant increase is also observed in other Northern European countries.
Until now, it was widely believed that around 0.1% of the Dutch population, equivalent to about 18,000 people, had MS. The new findings, based on data from MS patients born in 1966, indicate that the actual number is much higher.
Researchers attribute this substantial rise in prevalence to several factors. One key reason is the disparity between MS patients registered with GPs and those registered in hospitals. Patients with milder or more advanced forms of MS are less likely to be treated by a neurologist in a hospital setting, leading to underreporting in hospital data.
Moreover, improvements in registration methods and earlier diagnosis, driven by advancements in diagnostic criteria and more effective treatments, have also contributed to the higher estimates. These factors combined have resulted in a more accurate representation of the true MS prevalence in the Netherlands.
This new understanding of MS prevalence has significant implications for healthcare provision and research. It underscores the importance of accurate and comprehensive data in shaping policy and allocating resources to support people living with MS.
